Monsanto Co. (MON) Stock Rating Reaffirmed by Argus
Monsanto Co. (NYSE:MON)‘s stock had its “buy” rating restated by equities research analysts at Argus in a report issued on Sunday. They currently have a $128.00 target price on the stock. Argus’ price target would indicate a potential upside of 23.84% from the company’s previous close.
A number of other equities research analysts have also weighed in on the company. BMO Capital Markets reissued an “outperform” rating and issued a $128.00 target price on shares of Monsanto in a research note on Saturday. JPMorgan Chase & Co. set a $128.00 target price on Monsanto and gave the company a “buy” rating in a research note on Thursday. Zacks Investment Research lowered Monsanto from a “hold” rating to a “strong sell” rating in a research report on Friday. Deutsche Bank AG reaffirmed a “buy” rating on shares of Monsanto in a research report on Thursday. Finally, Barclays PLC reaffirmed a “hold” rating and set a $110.00 price target on shares of Monsanto in a research report on Thursday. Three analysts have rated the stock with a sell rating, eight have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $114.67.
Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. The firm has a 50-day moving average price of $104.86 and a 200-day moving average price of $101.43. The firm has a market cap of $45.23 billion, a PE ratio of 45.49 and a beta of 1.19. Monsanto has a 52 week low of $83.73 and a 52 week high of $114.26.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/09/monsanto-co-mon-stock-rating-reaffirmed-by-argus.html
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. During the same quarter in the previous year, the company posted ($0.19) EPS. Monsanto’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, equities research analysts predict that Monsanto will post $4.89 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be issued a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 2.09%. Monsanto’s payout ratio is 71.05%.
In other news, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares in the company, valued at $2,196,501.91. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in MON. Candriam Luxembourg S.C.A. bought a new position in shares of Monsanto during the second quarter worth approximately $12,767,000. Nisa Investment Advisors LLC boosted its position in shares of Monsanto by 3.2% in the second quarter. Nisa Investment Advisors LLC now owns 189,692 shares of the company’s stock worth $19,616,000 after buying an additional 5,890 shares in the last quarter. Shell Asset Management Co. boosted its position in shares of Monsanto by 7.7% in the second quarter. Shell Asset Management Co. now owns 131,594 shares of the company’s stock worth $13,608,000 after buying an additional 9,459 shares in the last quarter. Carmignac Gestion bought a new position in shares of Monsanto during the second quarter worth approximately $197,555,000. Finally, Legal & General Group Plc boosted its position in shares of Monsanto by 2.5% in the first quarter. Legal & General Group Plc now owns 1,944,838 shares of the company’s stock worth $170,663,000 after buying an additional 46,878 shares in the last quarter. 79.02% of the stock is currently owned by hedge funds and other institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.